Pharmacokinetic Study of Single Doses of ORM-12741
NCT02319057
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
ORM-12741 MR A
DRUG:
ORM-12741 IR
DRUG:
ORM-12741 MR B
Sponsor
Orion Corporation, Orion Pharma